| Date | Title | Description |
| 01.03.2022 | Cambridge graphene-based startup rakes in $60 million to rollout biosensor for healthcare industry | Cambridge-based graphene startup Paragraf has raised $60 million funding in a Series B round. The investment was led by US deep tech investor New Science Ventures and saw the participation of Molten Ventures alongside fellow current investo... |
| 06.10.2021 | BrightVolt Raises $16 Million in Series B Funding Led by New Science Ventures and Caterpillar Venture Capital Inc. | REDMOND, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- BrightVolt, Inc., a global leader in the design, development, and manufacturing of safe, high energy and low cost solid-state Lithium-Ion batteries has successfully closed the first tranche ... |
| 06.10.2021 | BrightVolt Raises $16 Million in Series B Funding Led by New Science Ventures and Caterpillar Venture Capital Inc. | REDMOND, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- BrightVolt, Inc., a global leader in the design, development, and manufacturing of safe, high energy and low cost solid-state Lithium-Ion batteries has successfully closed the first tranche ... |
| 13.12.2017 | New Science Ventures Joins 25M Euros Series A for NorthSea Therapeutics | NorthSea Therapeutics B.V. (‘NST’), a newly established Dutch biotech company, announced today the completion of a €25m Series A funding for the development of icosabutate, a structurally engineered fatty acid (‘SEFA’) as a novel, oral appr... |
| 19.01.2017 | India: Zeotap raises $12.8m from New Science Ventures, HERE | Premium
Zeotap GmbH, a Bangalore and Berlin-based mobile data platform, has raised $12.8 million (12 million euros) in Series B round from New Science Ventures and HERE, the company said in a statement.
Continue reading this story with a su... |
| 18.01.2017 | New Science Ventures, others invest $12.8 mn in Zeotap | Bangalore- and Berlin-based mobile data startup Zeotap GmbH has raised $12.8 million (12 million euros) in Series B funding from New Science Ventures (NSV) and Here.
NSV is a New York-based venture fund and Here is a global provider of mapp... |
| 17.01.2017 | Berlin’s zeotap raises €12 million to branch out from telecoms data | Germany’s zeotap has secured €12 million in a Series B round from New Science Ventures, HERE, Capnamic Ventures, and Iris Capital as well as several business angels.
zeotap is a data platform that has allowed telecoms and marketers to use p... |
| 18.09.2016 | New Science Ventures Leads $5M Series B for BrightVolt | BrightVolt Inc., the global leader in the design, development and scale manufacturing of ultra-thin film, flexible batteries, announced the opening of a Series B round of investment. Prominent scientific venture capital firm New Science Ven... |
| 18.09.2016 | New Science Ventures Leads $5M Series B for BrightVolt | BrightVolt Inc., the global leader in the design, development and scale manufacturing of ultra-thin film, flexible batteries, announced the opening of a Series B round of investment. Prominent scientific venture capital firm New Science Ven... |
| 15.09.2016 | BrightVolt raises $5M to open new funding round for ultra-thin, flexible batteries | BrightVolt says its flexible batteries are used in more than 10,000 commercial products.
BrightVolt, a Redmond, Wash., based startup developing ultra-thin batteries, announced the beginning of a Series B round of funding, starting with a $5... |
| 18.08.2016 | New Science Ventures Leads $6.5M Series B for VUV Analytics | VUV Analytics, Inc., the leader in vacuum ultraviolet (VUV) absorption spectroscopy, announced closing of a $6.5 million Series B equity financing. The round was led by new investor New Science Ventures, with participation from S3 Ventures ... |
| 14.03.2016 | Daily funding roundup - March 14, 2016 | LendInvest raised $25M; GV led $21M investment in Epigenetix; Arterys closed a $12M funding
LendInvest, a platform for peer-to-peer real estate investing, closed a £17 million (approximately $25 million) Series B funding round from Atomico,... |
| 16.02.2016 | Akarna Therapeutics Closes $15M Series B Financing | Akarna Therapeutics Ltd., a Cambridge, UK- and Encinitas, California-based biopharmaceutical company, closed a $15m Series B financing.
New investor Forbion Capital Partners joined existing investors New Science Ventures and Third Point Ven... |
| 16.11.2015 | Daily funding roundup - November 16, 2015 | Signostics secured $35M; LoveCrafts raised $20M; Varentec landed $13M
Wellmo, a Helsinki, Finland-based mobile solution to run digital health programs, raised €1 million (approximately $1.8 million) in seed funding. The backers remained und... |
| 03.11.2015 | Fuzzy Logix Raises $5.5M in Series A Funding | Fuzzy Logix, a Charlotte, North Carolina based startup that provides a predictive analytics platform for Big Data, raised $5.5m in Series A funding.
New Science Ventures made the investment.
The company intends to use the funds for business... |
| 18.09.2015 | Daily funding roundup - September 18, 2015 | Clover Health bagged $100M; Jaunt raised $50M; Establishment Labs closed $20M funding round
Travel Startups Incubator announced a $25,000 investment in VidPal, a travel and tourism video marketplace that provides paid opportunities to the f... |
| 01.09.2015 | Vorago Technologies Closes $10M Venture Capital Funding | Vorago Technologies (previously known as Silicon Space Technology), an Austin, TX-based provider of radiation- and extreme heat-hardened embedded systems technology, closed a $10m venture capital funding.
The round was led by New Science Ve... |
| 31.03.2015 | PerceptiMed raising $5M to commercialize medication validation tools to avoid patient error | Jennifer said the funding would be used to add staff across engineering, sales and marketing. She added that it’s working with national retail pharmacies.
For longterm care facilities, PerceptiMed developed a smaller version of its system, ... |
| 20.01.2015 | Vaultive Raises $8 Million to Advance Leadership in Cloud Data Encryption | Boston, MA — January 20, 2014 — Vaultive, the leader in cloud data encryption, today announced an $8 million dollar financing round, led by .406 Ventures, New Science Ventures and Harmony Partners. The company will use the new funding to fu... |
| 27.01.2014 | Buoyed by mobile health trends, TigerText raises $21M in Series B round | Co-founder and CEO Brad Brooks outlined a few examples of how the API is being used. Pathology Inc., a women’s health lab, is using it to send lab alerts to its physician customers. A partnership with Ontario-based PointClickCare helped exp... |
| 03.01.2014 | NeXeption Raises $21.5m in Series A to Form Alexar Therapeutics | NeXeption, LLC, a Malvern, PA-based biopharmaceutical management company, has secured $21.5m in Series A financing to form Alexar Therapeutics, Inc.
The round was led by New Science Ventures and Third Point Ventures with participation from ... |
| 02.01.2014 | Biopharma company raises $21.5M to treat inflammatory skin disorders | LXR agonists have generated interest as a source of life science innovation with the potential to treat conditions such as atherosclerosis and Alzheimer’s disease.
Dr. Neal Walker is a dermatologist and serial entrepreneur who will serve as... |
| 02.01.2014 | Alexar Therapeutics Launches with $21.5M |
MALVERN, PA, Biopharmaceutical management company that brings together product opportunities, management expertise and funding to reach compelling partnership milestones, announced today that it has secured $21.5 million in Series A finan... |
| 29.11.2013 | Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | Here’s how:
Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The Super... |
| 13.11.2013 | Solicore Holds First Close of Series A1 Financing | Solicore, a Lakeland, FL-based global provider of embedded power solutions, held the first close of its Series A1 round of financing.
The round was led by new investor New Science Ventures, which committed $4m in capital, with participation... |
| 12.11.2013 | Solicore Closes Initial Round of New Financing |
LAKELAND, FL, Global leader of embedded power solutions, today announced the first close of its Preferred Series A1 round of financing.
>> Click here for more funding data on Solicore
>> To export Solicore funding data to PD... |
| 27.02.2012 | Cloud Data Encryption Solutions Provider Vaultive Raises $10 Million | |
| 27.02.2012 | Vaultive keeps your data safe in the cloud, raises $10M | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Vaultive, which encrypts data before its gets sto... |
| 17.11.2011 | Oxyrane Raises $26.5M in Series D Funding | Oxyrane UK Limited, a Manchester, England, UK-based biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, has raised $26.5m in Series D funding round.
Backers inclu... |
| 11.01.2011 | Wound healing firm Celleration raises $8 million | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermin... |
| 29.10.2008 | BioLogix bags $6M for oncology drug, names new CEO | Biopharm company BioLogix raised $6 million in first-round equity and debt financing from Essex Woodlands Health Ventures and New Science Ventures. The money will be used to continue development of its top cancer-fighting compound, but a se... |
| 15.10.2008 | Achronix nabs $43M for gate array technology | Achronix Semiconductor Corp. recently closed $43 million of a large, still open $52 million second round of financing. Argonaut Private Equity led the tranche, which also included existing investors Battery Ventures, New Science Ventures, E... |
| 09.07.2007 | BioVex raises $22M for cancer-killing viruses | Woburn, Mass.-based BioVex, a biotech working on new ways to attack cancer and infections, raised $22 million in a fifth funding round. Triathlon Medical Ventures led the round, joined by New Science Ventures, Forbion Capital Ventures, Aval... |
| - | Cambridge graphene-based startup rakes in $60 million to rollout biosensor for healthcare industry | Cambridge-based graphene startup Paragraf has raised $60 million funding in a Series B round. The investment was led by US deep tech investor New Science Ventures and saw the participation of Molten Ventures alongside fellow current investo... |
| - | Buoyed by mobile health trends, TigerText raises $21M in Series B round | One significant area of health IT growth has been companies that have responded to the dual need for improving communication between medical staff to reduce errors and duplicated tests and the security challenges the growing Bring Your Own ... |
| - | PerceptiMed raising $5M to commercialize medication validation tools to avoid patient error | The statistic that PerceptiMed CEO and co-founder Dr Alan Jacobs throws at me sounds terrible — one out of 30 pills is an incorrect drug or dosage or goes to the wrong person. It is part of the challenge to improve patient safety that’s pro... |
| - | Biopharma company raises $21.5M to treat inflammatory skin disorders | A biopharma management company has created a new business that will use liver X receptor agonists to take on dermatological disorders. NeXeption has raised $21.5 million in a Series A financing round to form Alexar Therapeutics, according t... |
| - | Wound healing firm Celleration raises $8 million | Eden Prairie-based Celleration has raised $8 million in Series E stock toward more sales and marketing resources for its mist therapy wound healing product.
CEO Mark Wagner, who joined the company in 2009, said by phone that Celleration att... |
| - | Leonid Capital Partners: How This Firm Is Accelerating Innovators In Government And Defense Technology | Leonid Capital Partners is a leading investment firm that is focused on identifying and supporting high-growth technology companies that work in the national security sector. Pulse 2.0 interviewed Leonid Capital Partners co-founders Chris L... |
| - | Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized “super-saturated oxygen” (SSO2) offers a ... |
